Followers | 2458 |
Posts | 79992 |
Boards Moderated | 0 |
Alias Born | 06/15/2009 |
Monday, January 13, 2020 11:09:54 AM
Recent VRNA News
- Verona Pharma to Present at Jefferies London Healthcare Conference • GlobeNewswire Inc. • 11/05/2024 07:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/04/2024 01:47:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2024 11:06:03 AM
- Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/04/2024 07:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/01/2024 11:17:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/01/2024 11:13:20 PM
- Verona Pharma to Report Third Quarter 2024 Financial Results and Provide Corporate Update • GlobeNewswire Inc. • 10/21/2024 06:00:00 AM
- Verona Pharma to Present Six Analyses of the Phase 3 ENHANCE Studies in COPD at CHEST 2024 • GlobeNewswire Inc. • 09/30/2024 06:00:00 AM
- Verona Pharma to Present Additional Analyses of Phase 3 ENHANCE Studies in COPD at ERS International Congress 2024 • GlobeNewswire Inc. • 09/05/2024 06:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/09/2024 11:12:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 12:51:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 12:44:28 PM
- Verona Pharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/08/2024 06:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 01:28:45 AM
- Verona Pharma to Present at 44th Annual Canaccord Growth Conference • GlobeNewswire Inc. • 07/30/2024 06:00:00 AM
- Verona Pharma to Report Second Quarter 2024 Financial Results and Provide Corporate Update • GlobeNewswire Inc. • 07/25/2024 06:00:00 AM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 07/12/2024 08:04:11 PM
- Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine) • GlobeNewswire Inc. • 06/26/2024 08:57:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 01:09:53 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/10/2024 12:53:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:22:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:18:24 AM
- Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/09/2024 11:15:00 AM
- Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS • GlobeNewswire Inc. • 05/09/2024 11:00:00 AM
- Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024 • GlobeNewswire Inc. • 05/02/2024 06:00:00 AM
FEATURED North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM